CRNX

Crinetics Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$37.23

Market Cap

$3.90B

Beta

0.24

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+421.66%

EPS Growth (YoY)-33.42%

Revenue CAGR 3Y+4.59%

P/E Ratio0.0

PEG Ratio—

FCF Yield-9.84%

Debt / Equity0.05

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for CRNX.